Diana Brainard - Nov 19, 2024 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Executive Officer, Director
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Nov 19, 2024
Transactions value $
-$4,775
Form type
4
Date filed
11/20/2024, 04:15 PM
Previous filing
Nov 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$4.78K -8.71K -1.19% $0.55 723K Nov 19, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.545 to $0.572. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.